Student: Vincent Xue
Lab: Keating
Title: Modeling and Designing Bcl-2 Family Protein Interactions Using High-Throughput Interaction Data
Image Credit:Geoff Fudenberg and Leonid Mirny
Research in Molecular Biophysics and Structural Biology at MIT studies fundamental properties of molecules and systems, often by integrating computational thinking, engineering designs, and biophysical insights.
Student: Vincent Xue
Lab: Keating
Title: Modeling and Designing Bcl-2 Family Protein Interactions Using High-Throughput Interaction Data
Drug that targets a key cancer protein could combat leukemia and other types of cancer.
MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive.
The new peptide targets a protein called Mcl-1, which helps cancer cells avoid the cellular suicide that is usually induced by DNA damage. By blocking Mcl-1, the peptide can force cancer cells to undergo programmed cell death.
An abundant enzyme in marine microbes may be responsible for production of the greenhouse gas.